MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 71 filers reported holding MINERVA NEUROSCIENCES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,000 | -76.2% | 30,096 | -48.0% | 0.00% | -77.8% |
| Q3 2021 | $101,000 | +180.6% | 57,845 | +275.9% | 0.01% | +200.0% |
| Q2 2021 | $36,000 | -74.6% | 15,389 | -74.6% | 0.00% | -80.0% |
| Q4 2020 | $142,000 | +264.1% | 60,559 | +463.3% | 0.02% | +200.0% |
| Q2 2020 | $39,000 | -66.4% | 10,751 | -29.3% | 0.01% | -16.7% |
| Q3 2017 | $116,000 | – | 15,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Associates V Ltd | 911,836 | $5,516,000 | 8.00% |
| HIGHLAND CAPITAL MANAGEMENT LP | 2,160,544 | $13,072,000 | 0.60% |
| DAFNA Capital Management LLC | 171,094 | $1,035,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 775,000 | $4,689,000 | 0.55% |
| Cormorant Asset Management, LP | 607,903 | $3,678,000 | 0.38% |
| ASCEND CAPITAL, LLC | 819,347 | $4,957,000 | 0.19% |
| FEDERATED HERMES, INC. | 7,535,287 | $45,588,000 | 0.13% |
| Kazazian Asset Management, LLC | 10,410 | $63,000 | 0.06% |
| Artal Group S.A. | 251,300 | $1,520,000 | 0.02% |
| Trexquant Investment LP | 27,950 | $169,000 | 0.02% |